Julie Smith
CIK 1557928 · President and CEO · last filed 2026-06-05
Julie Smith is a President and CEO who has filed 35 SEC Form 4 insider transactions across 4 companies since 2012. The most recent filing, for STOK, was dated Jun 5, 2026. Across all open-market trades the lifetime net is −$8.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.54M
4
35
-$8.07M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| STOK | Director | — | $29.82 | — | $0 | 7 | 2026-06-05 |
| EXEL | Director | 28,957 | $53.13 | $1.54M | -$8.07M | 16 | 2026-05-29 |
| BOLD | Director | — | $1.41 | — | $0 | 5 | 2020-01-15 |
| Raptor Pharmaceutical Corp (RPTP) Delisted | President and CEO | 64,179 | — | — | $0 | 7 | 2016-10-26 |
Recent Filings
35 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-05 | STOK | Grant (A) | — | $0 | EDGAR |
| 2026-05-29 | EXEL | Grant (A) | +8,367 | $0 | EDGAR |
| 2026-02-19 | EXEL | Mixed | — | -$2.63M | EDGAR |
| 2025-06-04 | STOK | Grant (A) | — | $0 | EDGAR |
| 2025-05-30 | EXEL | Grant (A) | +9,812 | $0 | EDGAR |
| 2025-02-28 | EXEL | Mixed | — | -$1.32M | EDGAR |
| 2024-08-15 | EXEL | Other (J) | −4,682 | $0 | EDGAR |
| 2024-06-07 | STOK | Grant (A) | — | $0 | EDGAR |
| 2024-06-04 | EXEL | Grant (A) | +10,015 | $0 | EDGAR |
| 2024-05-23 | EXEL | Sell (S) | −27,280 | -$576.2K | EDGAR |